Abstract：
PURPOSE:To investigate Axxent (iCAD, Inc., San Jose, CA) electronic brachytherapy balloon deformation and its dosimetric impact because of an external flexible shield (FlexiShield [FS]; iCAD, Inc.). METHODS AND MATERIALS:Prostheses breast tissue phantom overlaid three spherical balloon applicators to simulate three clinical scenarios depending on minimum skin-to-balloon surface spacing (SS): balloon with SS of 2 cm, 1 cm, and balloon with 1 cm SS and touching the chest wall. Two sets of megavoltage CT (MVCT) scans were obtained with or without FS for 15 different sizes of balloons. For 45 pairs of MVCT scans, balloon deformation was measured in superior-inferior (dSI) dimension on coronal and sagittal planes and anterior-posterior (dAP) and lateral (dLAT) dimensions on the equatorial plane of balloon. SS was also compared. A treatment plan was made on each MVCT scan. Doses at four balloon surface points and skin were compared. Conformity index value was also compared to evaluate three-dimensional dose distribution. Clinically, 20 Gy was prescribed to the surface of balloon. RESULTS:Balloon deformation was observed with compression in SI and AP dimensions and expansion in lateral dimension. Average SI compression was 0.5 mm. Average dLat - dAP was 2.4 mm, which resulted in elevated point doses at AP dimension by 10.8% of prescribed dose and reduced point doses at lateral dimension by 4.6%. FS decreased SS by 1.8 mm, increasing skin dose by 1.2 Gy, on average. Conformity index value was decreased from 0.922 to 0.908, on average. CONCLUSIONS:This phantom study demonstrates that use of skin shielding during breast intraoperative radiation therapy can cause balloon deformation and SS reduction, resulting in dosimetric changes that are disregarded in current practice.
journal_name
Brachytherapyjournal_title
Brachytherapyauthors
Kim Y,Huynh JW,Gonzalez VJdoi
10.1016/j.brachy.2017.01.009subject
Has Abstractpub_date
2017-01-01 00:00:00pages
597-607issue
3eissn
1538-4721issn
1873-1449pii
S1538-4721(17)30015-6journal_volume
16pub_type
杂志文章相关文献
Brachytherapy文献大全abstract：PURPOSE:(1) To demonstrate the feasibility of C-arm cone-beam computed tomography (CBCT)-based postplanning and subsequent adaptation of underdosed critical areas by adding remedial seeds during the transrectal ultrasound (TRUS)-guided implantation of (125)I seeds and (2) to assess the duration of this procedure. METH...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2007.08.005
更新日期：2007-10-01 00:00:00
abstract：PURPOSE:African American men have historically had poorer prostate cancer biochemical and survival outcomes than Caucasians. However, emerging data suggest nononcologic factors drive much of this disparity. Prior evidence has suggested an association between a transient prostate specific antigen (PSA) bounce and improv...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2019.08.008
更新日期：2020-01-01 00:00:00
abstract：PURPOSE:Given the limited data using an interstitial approach with 3D-based planning for definitive cervical cancer utilizing the GEC-ESTRO defined high-risk clinical target volume (HR-CTV), we reviewed our institutional experience of cervical cancer patients with HR-CTVs ≥ 30 cc to determine whether our clinical and t...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2017.10.004
更新日期：2018-01-01 00:00:00
abstract：PURPOSE:This is a retrospective review of our experience using high-dose-rate (HDR) brachytherapy boost for prostate cancer. METHODS AND MATERIALS:During the study period, we recommended external beam radiotherapy (45 Gy) and HDR boost (18 Gy in three fractions) combined with hormonal therapy (HT) for 2 months before ...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2005.03.005
更新日期：2005-01-01 00:00:00
abstract：PURPOSE:With an aim to evaluate and report high dose date interstitial brachytherapy (HDR-ISBT) in vulvar cancers, we undertook this retrospective analysis. METHODS AND MATERIALS:Histologically proven vulvar cancers treated with HDR-ISBT between 2001 and 2016 were analyzed. Radiotherapy details, clinical outcome in te...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2016.10.003
更新日期：2017-01-01 00:00:00
abstract：PURPOSE:This work quantifies the influence of intrafraction DNA damage repair and cellular repopulation on biologically effective dose (BED) in Ir-192 high-dose-rate brachytherapy for prostate cancer. In addition, it examines the effect of source-decay-induced BED variation for patients treated at different time points...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2019.04.005
更新日期：2019-01-01 00:00:00
abstract：PURPOSE:To estimate the difference in income generated if all women presenting in our institute over a 5-year period were treated with MRI-based image-guided brachytherapy (MR-IGBT) instead of conventional radiograph-based brachytherapy (CR-BT). METHODS AND MATERIALS:Outcome data from 463 patients (94 treated with MR-...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2017.05.003
更新日期：2017-01-01 00:00:00
abstract：PURPOSE:To compare a standard radio-oncological and a surgical biochemical failure definition after combined-modality radiation therapy (CRT) in men with intermediate- and high-risk prostate cancer. METHODS:425 men were treated with external beam radiotherapy (59.4 Gy, 33 fractions) and 125J seed-brachytherapy (S-BT, ...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2019.09.001
更新日期：2020-01-01 00:00:00
abstract：OBJECTIVES:Men with higher body mass index (BMI) tend to have more fatty tissue in prostate-rectum interface, which may reduce the rectal wall dose by the inverse square law. We hypothesized that men with higher BMI will have a lower dose to the rectal wall and less rectal toxicity after permanent prostate implant. ME...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2008.12.001
更新日期：2009-04-01 00:00:00
abstract：PURPOSE:High-dose-rate (HDR) brachytherapy is a convenient treatment option for selected patients with T1-T2 penile squamous cell carcinoma (SCC), providing high rates of penile preservation and tumor control. We present the results of penile SCC treated with HDR brachytherapy either interstitially or via a surface mol...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2019.12.003
更新日期：2020-01-01 00:00:00
abstract：UNLABELLED:PURPOSE/INTRODUCTION: To safely irradiate retroperitoneal targets as paraaortic lymph node by separating abdominal at-risk organs from the target during irradiation, we created a percutaneous paravertebral approach of high-dose-rate brachytherapy with hyaluronate gel injection (HGI). We report a case treated...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2011.12.004
更新日期：2013-01-01 00:00:00
abstract：PURPOSE:The treatment of locally advanced cervical cancer with definitive chemoradiation (CRT) is associated with vaginal toxicity and altered sexual satisfaction. This prospective study assessed patient-reported sexual adjustment, vaginal dosimetry, and physician-reported vaginal toxicity in patients with cervical can...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2018.09.005
更新日期：2019-01-01 00:00:00
abstract：PURPOSE:Limited information is available comparing target volume and normal tissue dosimetry with the different techniques of partial breast irradiation (PBI). We present results of a dosimetric comparison of single catheter, balloon-based brachytherapy using the MammoSite catheter (BRT), 3D conformal radiation therapy...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2006.06.001
更新日期：2006-07-01 00:00:00
abstract：OBJECTIVE:To compare dosimetrically the stereotactic CyberKnife (CK) therapy and multicatheter high-dose-rate (HDR) brachytherapy (BT) for accelerated partial breast irradiation (APBI). METHODS:Treatment plans of 25 patients treated with CK were selected, and additional plans using multicatheter HDR BT were created on...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2020.10.003
更新日期：2020-11-18 00:00:00
abstract：PURPOSE:High-dose-rate (HDR) brachytherapy boost is a treatment of intermediate- to high-risk prostate cancer, but long-term clinical outcome data are sparse. We report long-term survival and toxicity data in a cohort of patients treated in a single institution. METHODS:Between 1998 and 2004, 654 patients with localiz...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2019.01.013
更新日期：2019-01-01 00:00:00
abstract：PURPOSE:To evaluate the impact of general versus spinal anesthesia on postprocedure narcotic use and of extradepartmental planning MRI on treatment time in high-dose-rate brachytherapy for cervical cancer. METHODS AND MATERIALS:Twenty-five patients (10 general anesthesia and 15 spinal anesthesia) who collectively rece...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2018.05.002
更新日期：2018-01-01 00:00:00
abstract：PURPOSE:Education and training on prostate brachytherapy for radiation oncology and medical physics residents in the United States is inadequate, resulting in fewer competent radiation oncology personnel to perform implants, and is a factor in the subsequent decline of an important, potentially curative cancer treatmen...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2020.10.001
更新日期：2020-01-01 00:00:00
abstract：:A 17-year-old girl diagnosed with a previously irradiated, locally recurrent Ewing's sarcoma involving the puboischiatic rami and the adjacent acetabulum was referred to our institution for consideration of salvage hindquarter resection. A conservative resection with implantation of the acetabular remnant for high-dos...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/S1538-4721(03)00098-9
更新日期：2003-01-01 00:00:00
abstract：PURPOSE:To evaluate lumpectomy followed by interstitial brachytherapy as an acceptable salvage therapy for women who have developed localized recurrence of breast cancer after conservation surgery and postoperative external radiotherapy. METHODS AND MATERIALS:Between 1/1998 and 10/2006, 21 patients with T0 or T1 in-br...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2007.12.001
更新日期：2008-01-01 00:00:00
abstract：PURPOSE:To evaluate the effectiveness of the single-energy metal artifact reduction (SEMAR) technique for improving the accuracy of I-125 seed identification in postimplant computed tomography (CT) after prostate brachytherapy. METHODS AND MATERIALS:Postimplant CT images of 40 patients treated with I-125 prostate brac...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2016.07.006
更新日期：2016-01-01 00:00:00
abstract：PURPOSE:To determine whether potential extraprostatic extension (EPE) of prostate adenocarcinoma is covered by the prescribed dose when permanent 125I implants are planned with a 5-mm treatment margin. METHODS AND MATERIALS:The postimplant dosimetry of 60 consecutive 125I prostate implants was analyzed to determine wh...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2003.09.002
更新日期：2003-01-01 00:00:00
abstract：PURPOSE:The aim of this work was to analyze the results of palliative HDR brachytherapy in patients with advanced esophageal cancer. METHODS AND MATERIALS:Ninety-one patients with unresectable, advanced esophageal cancer were treated palliatively by HDR brachytherapy. All patients received a total dose of 22.5 Gy in t...
journal_title：Brachytherapy
pub_type： 临床试验,杂志文章
doi：10.1016/j.brachy.2004.05.003
更新日期：2004-01-01 00:00:00
abstract：PURPOSE:Determine whether fat distribution, body mass index, or clinical and dosimetric factors are associated with prostate specific antigen (PSA) bounce (PSAb) of ≥1.6 ng/mL in patients treated with permanent seed (125)I prostate brachytherapy (PB). METHODS AND MATERIALS:We identified 23 patients with a PSAb of ≥1.6...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2013.05.005
更新日期：2013-11-01 00:00:00
abstract：PURPOSE:Treatment of locally advanced cervical cancer in patients with a renal graft requires precautions. The graft is usually in a pelvic position, close to the clinical target volume (CTV). Preserving the graft while ensuring local control is a challenge we have faced in two occasions. We report our experience. MET...
journal_title：Brachytherapy
pub_type： 社论
doi：10.1016/j.brachy.2013.11.003
更新日期：2014-01-01 00:00:00
abstract：PURPOSE:The purpose of this work was to evaluate whether the delivered dose to the skin surface and at the prescription depth when using a Freiburg flap applicator is in agreement with the one predicted by the treatment planning system (TPS) using the TG-43 dose-calculation formalism. METHODS AND MATERIALS:Monte Carlo...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2011.11.005
更新日期：2012-11-01 00:00:00
abstract：PURPOSE:The aim of this work was to analyze the exposure rates measured in the proximity of patients who underwent prostate low-dose-rate brachytherapy with I-125 implant. Effective doses to relatives and to population were computed to estimate the time to reach radioprotection dose constraints. METHODS AND MATERIALS:...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2020.09.003
更新日期：2021-01-01 00:00:00
abstract：PURPOSE:To assess the difference in prostate-specific antigen (PSA) response kinetics in patients undergoing either (125)I or (103)Pd permanent prostate brachytherapy (PPB). METHODS AND MATERIALS:Between 1997 and 1999, 333 patients underwent PPB as monotherapy. Forty-eight patients received a (125)I implant, and 285 r...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/S1538-4721(03)00004-7
更新日期：2003-01-01 00:00:00
abstract：PURPOSE:To describe in detail British Columbia (BC) Cancer Agency (BCCA) Provincial Prostate Brachytherapy (PB) Quality Assurance (QA) Program. METHODS AND MATERIALS:The BCCA PB Program was established in 1997. It operates as one system, unified and supported by electronic and information systems, making it a single P...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2012.03.006
更新日期：2013-07-01 00:00:00
abstract：BACKGROUND:Prostate cancer incidence in the African-Caribbean population ranks among the highest worldwide. We aim to evaluate the prostate-specific antigen (PSA) kinetics after brachytherapy, which so far remains unknown in this population. METHODS AND MATERIALS:From 2005 to 2013, 371 patients received (125)I brachyt...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2015.09.005
更新日期：2015-11-01 00:00:00
abstract：PURPOSE:Symptomatic coronary artery disease is routinely treated with angioplasty and stenting. Unfortunately, treatment failure in the form of in-stent restenosis (ISR) occurs relatively frequently. Intravascular brachytherapy (IVBT) is a safe and effective method proven to markedly reduce the rate of ISR in native co...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2004.05.004
更新日期：2004-01-01 00:00:00
